Annual Report

Overview

The report describes the company's transition from a development-stage organization to a commercial enterprise following the U.S. launch of PancreaSure in September 2025. By year-end, twelve high-risk surveillance centers had implemented the test, while five clinical studies were published and CAP accreditation was received for the North Carolina laboratory.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 10 April 2026
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services